Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial

Peter Richmond, Helen Marshall, Michael D. Nissen, Qin Jiang, Kathrin U. Jansen, María Garcés‐Sánchez, Federico Martinón‐Torres, Johannes Beeslaar, Leszek Szenborn, Jacek Wysocki,

The Lancet Infectious Diseases · 2012 · 131 citations · 24 references

DOIFull text

Open access

Concepts

References

24